These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15940344)

  • 1. Adeno-associated virus vector-mediated gene delivery to the vasculature and kidney.
    Kapturczak MH; Chen S; Agarwal A
    Acta Biochim Pol; 2005; 52(2):293-9. PubMed ID: 15940344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus vectors for vascular gene delivery.
    Lynch CM; Hara PS; Leonard JC; Williams JK; Dean RH; Geary RL
    Circ Res; 1997 Apr; 80(4):497-505. PubMed ID: 9118480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adeno-associated viral vectors: background and technical aspects.
    Snoeck HW; Tao W; Klotman ME
    Exp Nephrol; 1997; 5(6):514-20. PubMed ID: 9438181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium.
    Tsai ML; Chen SL; Chou PI; Wen LY; Tsai RJ; Tsao YP
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):751-7. PubMed ID: 11867594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus vector: Is it ideal for gene delivery in liver transplantation?
    Yang ZF; Wu XB; Tsui TY; Hou YD; Luk JM; Fan ST
    Liver Transpl; 2003 Apr; 9(4):411-20. PubMed ID: 12682895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus-mediated gene delivery.
    Snyder RO
    J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries.
    Wang T; Li H; Zhao C; Chen C; Li J; Chao J; Chao L; Xiao X; Wang DW
    Gene Ther; 2004 Sep; 11(17):1342-50. PubMed ID: 15175642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.
    Sen S; Conroy S; Hynes SO; McMahon J; O'Doherty A; Bartlett JS; Akhtar Y; Adegbola T; Connolly CE; Sultan S; Barry F; Katusic ZS; O'Brien T
    J Gene Med; 2008 Feb; 10(2):143-51. PubMed ID: 18067196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
    Stachler MD; Bartlett JS
    Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.
    Sumner-Jones SG; Gill DR; Hyde SC
    J Virol; 2007 Nov; 81(22):12360-7. PubMed ID: 17855531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of recombinant adeno-associated virus for skeletal gene therapy.
    Dai J; Rabie AB
    Orthod Craniofac Res; 2007 Feb; 10(1):1-14. PubMed ID: 17284242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes.
    Kapturczak MH; Flotte T; Atkinson MA
    Curr Mol Med; 2001 May; 1(2):245-58. PubMed ID: 11899074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
    Chadeuf G; Ciron C; Moullier P; Salvetti A
    Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.